---
title: "Smith & Nephew Executives Boost Holdings with July ADS Purchases"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293336188.md"
description: "Smith & Nephew executives, including CEO Deepak Nath and President Paul Connolly, purchased ADSs under the Employee Stock Purchase Plan on July 10, 2026. This insider buying signals alignment with shareholders. While analyst ratings remain a 'Hold' with a $30 target, TipRanks’ AI Analyst Spark rates SNN as an 'Outperform', citing improving financial performance and positive technicals despite near-term tariff headwinds."
datetime: "2026-07-21T11:44:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293336188.md)
  - [en](https://longbridge.com/en/news/293336188.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293336188.md)
---

# Smith & Nephew Executives Boost Holdings with July ADS Purchases

Smith & Nephew Snats ( (SNN) ) just unveiled an announcement.

On July 21, 2026, Smith & Nephew disclosed that several senior executives purchased American Depositary Shares under the company’s Employee Stock Purchase Plan. The transactions, reported in line with UK Market Abuse Regulation, involved ADSs listed on the New York Stock Exchange and were executed on July 10, 2026.

Chief Executive Officer Deepak Nath and President of Global Operations Paul Connolly each bought 434.02369 ADS at $24.48, while Sports Medicine President Scott Schaffner acquired 256.65972 ADS at the same price. The filing underscores ongoing insider participation in the group’s share incentive arrangements, signaling continued alignment between top management and shareholders and providing transparent insight into leadership’s exposure to the company’s equity.

The most recent analyst rating on (SNN) stock is a Hold  
with a $30.00 price target.  
To see the full list of analyst forecasts on Smith & Nephew Snats stock,  
see the SNN Stock Forecast page.

**Spark’s Take on SNN Stock**

According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.

The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.

To see Spark’s full report on SNN stock,  
click here.

**More about Smith & Nephew Snats**

Smith & Nephew plc is a U.K.-based medical technology company focused on orthopaedics, sports medicine and wound management products, serving hospitals and healthcare providers worldwide. Its shares trade in London with American Depositary Shares listed on the New York Stock Exchange, giving the group broad access to international capital markets.

The company offers surgical implants, advanced wound care solutions and sports medicine devices aimed at improving patient outcomes and reducing healthcare costs. Its diversified portfolio and global footprint position Smith & Nephew as a significant player in the medical devices sector, with a leadership team that participates in equity-based compensation schemes aligned with shareholder interests.

**Average Trading Volume:** 1,427,566

**Technical Sentiment Signal:** Hold

**Current Market Cap:** $13.01B

Learn more about SNN stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [SNN.US](https://longbridge.com/en/quote/SNN.US.md)

## Related News & Research

- [Smith & Nephew’s Kashyap sells shares worth GBP 101,672 to cover tax on award vesting](https://longbridge.com/en/news/295685894.md)
- [Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics | SNN Stock News](https://longbridge.com/en/news/296188344.md)
- [Smith & Nephew Discloses Increased Cevian Stake Above 13%](https://longbridge.com/en/news/290954042.md)
- [Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO](https://longbridge.com/en/news/296019005.md)
- [Cevian Capital Lifts Smith & Nephew Stake Above 14% in Late-July Disclosure](https://longbridge.com/en/news/293926975.md)